Virginie Lucas

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

Nöel Milpied, Éric Deconinck, Fanny Gaillard et al. · New England Journal of Medicine · 2004 · 341 citations · Full text

Medicine, Hematology, Oncology +13

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen

Thierry André, M.A. Bensmaïne, Christophe Louvet et al. · Journal of Clinical Oncology · 1999 · 280 citations

Medicine, Oncology, Pharmacology +13

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95

Audrey Simon, Michel Péoc’h, Philippe Casassus et al. · British Journal of Haematology · 2010 · 165 citations · Full text

Medicine, Hematology, Oncology +12

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.

Richard L. Schilsky, John Hohneker, Mark J. Ratain et al. · Journal of Clinical Oncology · 1998 · 105 citations

Medicine, Oncology, Pharmacology +17